This open-label , active-comparator study ( NCT@ ) randomized subjects @:@ to ETN @ mg/wk + MTX or investigator-selected DMARD ( sulfasalazine or hydroxychloroquine ) + MTX ( ETN + MTX , n = @ ; DMARD + MTX , n = @ ) .